
14.6K
Downloads
56
Episodes
IPA’s What, Why & How podcast unravels the intricacies of pharmacy and healthcare law and regulation, from Congress to the Board of Pharmacy. Each month, IPA’s CEO, Kate Gainer, welcomes a special guest to explore WHAT changes occurred, WHY action was taken, and HOW these changes will impact pharmacy practice.
Episodes
Friday Aug 26, 2022
Episode #40: August 2022 – Rulemaking Process, Compounding & IMP3 Program
Friday Aug 26, 2022
Friday Aug 26, 2022
Following the August 24 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the rulemaking process and how a rule is adopted, as well as the Board’s newly adopted compounding rule. In addition, Becky Carlson speaks on the IMP3 Program and its importance in Iowa.
Thursday Jun 30, 2022
Episode #39: June 2022 – Updated Security Rules & Statewide Protocol Changes
Thursday Jun 30, 2022
Thursday Jun 30, 2022
Following the June 28 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the Board’s updated security and controlled substance accountability rules, as well as changes to the Statewide Protocols for naloxone, immunization and tobacco cessation.
Thursday May 05, 2022
Episode #38: May 2022 – Compounding Pharmacies, Comment Periods & Security Changes
Thursday May 05, 2022
Thursday May 05, 2022
Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.
Wednesday Mar 09, 2022
Episode #37: March 2022 – Controlled Substances, Practicing Nurses & Telepharmacy
Wednesday Mar 09, 2022
Wednesday Mar 09, 2022
Following the March 1 Iowa Board of Pharmacy meeting, IPA’s Vice President of Government Affairs, Brett Barker, and Sue Mears from the Board of Pharmacy discuss the Board’s 2022 legislation regarding controlled substances and the authority of nurses practicing under a pharmacist’s order, as well as recent rulemaking and telepharmacy provisions from the Board.
Friday Jan 14, 2022
Friday Jan 14, 2022
Following the January 11 Iowa Board of Pharmacy meeting, IPA’s Government Relations team, Damian Thompson and Brett Barker, and Sue Mears from the Board of Pharmacy discuss federal comment periods for USP revisions, the DEA rulemaking regarding telepharmacy and transfer of electronic prescriptions for controlled substances, as well as recent rulemaking from the Board.
Thursday Nov 11, 2021
Episode #35: November 10 – Telepharmacy, Technicians & Upcoming Legislation
Thursday Nov 11, 2021
Thursday Nov 11, 2021
Following the November 10 Iowa Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss rule changes impacting telepharmacy, technicians, and potential legislation in the 2022 session.
Thursday Sep 02, 2021
Episode #34: August 31 – Collaborative Practice Rules and Test & Treat Protocols
Thursday Sep 02, 2021
Thursday Sep 02, 2021
Following the August 31 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss the recently noticed collaborative practice rules and board approved test and treat protocols.
Friday Jul 16, 2021
Friday Jul 16, 2021
Following the July 14 Board of Pharmacy meeting, IPA’s Vice President of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss emergency rules impacting pharmacy technician administered vaccines, updated statewide protocols, and next steps for new collaborative practice rules.